Phase I tolerability/safety of sunitinib in combination with capecitabine in patients (pts) with advanced solid tumors

被引：0
|
作者：
Verschraegen, C. [1 ]
Sweeney, C. [2 ]
Chiorean, G. [2 ]
Lee, F. C. [1 ]
Jones, S. [3 ]
Tye, L. [4 ]
Bello, A. [5 ]
Chao, R. [4 ]
Burris, H., III
机构：
[1] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA
[2] Indiana Univ, Indiana Univ Canc Ctr, Indianapolis, IN USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Pfizer Inc, La Jolla, CA USA
[5] Pfizer Inc, New York, NY USA
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70513-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
714
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] Tolerability/safety of sunitinib (SU) on schedule 2/1 in combination with capecitabine (C) in patients (pts) with advanced solid tumors (STs): A phase I dose-finding study
    Chiorean, E. G.
    Sweeney, C. J.
    Verschraegen, C. F.
    Lee, F. C.
    Jones, S. F.
    Rabinowitz, I.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors
    Sweeney, Christopher J.
    Chiorean, E. Gabriela
    Verschraegen, Claire F.
    Lee, Fa Chyi
    Jones, Suzanne
    Royce, Melanie
    Tye, Lesley
    Liau, Katherine F.
    Bello, Akintunde
    Chao, Richard
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4513 - 4520
  • [3] Phase I safety and pharmacokinetic (PK) study of sunitinib (S) in combination with ifosfamide (I) in patients (pts) with advanced solid tumors (STs)
    Hamberg, P.
    Steeghs, N.
    Loos, W. J.
    van der Biessen, D. J.
    den Hollander, M. A.
    Tascilar, M.
    Verweij, J.
    Gelderblom, H.
    Sleijfer, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] A phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Tang, P.
    Oza, A.
    Townsley, C.
    Siu, L.
    Pond, G.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J.
    Chen, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Phase I study of sunitinib (SU) in combination with pemetrexed (Pem) in patients (pts) with advanced solid tumors (ST)
    Nakagawa, K.
    Okamoto, I.
    Shimizu, T.
    Miyazaki, M.
    Tsurutani, J.
    Ichikawa, Y.
    Terashima, M.
    Takeda, M.
    Fumita, S.
    Kiriyama, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Phase I study of sunitinib (SU) in combination with pemetrexed (Pem) in patients (pts) with advanced solid tumors (ST)
    Nakagawa, Kazuhiko
    Okamoto, Isamu
    Shimizu, Toshio
    Miyazaki, Masaki
    Tsurutani, Junji
    Ichikawa, Yasuko
    Terashima, Masaaki
    Takeda, Masayuki
    Fumita, Soichi
    Kiriyama, Tsukasa
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S701 - S701
  • [7] Expanded phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Townsley, C.
    Oza, A. M.
    Tang, P.
    Siu, L. L.
    Pond, G. R.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J. A.
    Chen, E. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [9] A phase I dose escalation study of sunitinib plus capecitabine in patients with advanced solid tumors
    Sweeney, C.
    Verschraegen, C.
    Chiorean, G.
    Lee, F.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] A phase I dose-finding study of sunitinib (SU) in combination with gemcitabine (G) in patients (pts) with advanced solid tumors
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345